Your session is about to expire
← Back to Search
Imaging Agent + Ultrasound for Prostate Cancer
Study Summary
This trial will test if perflutren lipid microspheres can be used to safely and effectively diagnose prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a man aged 18 or older.I agree to have a special ultrasound of my prostate before surgery.I am scheduled for a surgery to remove my prostate due to cancer.I have received treatment for prostate cancer, including hormone therapy.
- Group 1: Diagnostic (perflutren lipid microspheres, ultrasound)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research opportunity still available to new participants?
"The listing on clinicaltrials.gov does show that the research team is currently looking for participants. This trial was first listed on June 15th, 2022 and has had two updates since then. They are hoping to enroll 50 people total at a single site."
What are some risks associated with Ultrasound use?
"Ultrasound has received a score of 3 from our Power team. This is based on the fact that it is a Phase 3 trial, meaning that there is both evidence of efficacy and multiple rounds of data supporting safety."
Could you elaborate on how many people are participating in this trial?
"The clinical trial is currently ongoing and looking for 50 patients from 1 site, as stated on clinicaltrials.gov. The trial was originally posted on 6/15/2022 and most recently updated on 6/17/2022."
Share this study with friends
Copy Link
Messenger